Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial-Reference-Cited by-同舟云学术

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Published:2013-07 Issue:8 Volume:14 Page:697-710
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Vermorken Jan B,Stöhlmacher-Williams Jan,Davidenko Irina,Licitra Lisa,Winquist Eric,Villanueva Cristian,Foa Paolo,Rottey Sylvie,Skladowski Krzysztof,Tahara Makoto,Pai Vasant R,Faivre Sandrine,Blajman Cesar R,Forastiere Arlene A,Stein Brian N,Oliner Kelly S,Pan Zhiying,Bach Bruce A

Publisher

Elsevier BV

Subject

Oncology

Reference48 articles.

1. NCCN clinical practice guidelines in oncology: head and neck cancers, version 1.2009,2008

2. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck;Jacobs;J Clin Oncol,1992

3. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study;Forastiere;J Clin Oncol,1992

4. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

5. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group;Gibson;J Clin Oncol,2005

Cited by 392 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review;Frontiers in Oncology;2024-08-22

2. The pro-tumoral and anti-tumoral roles of EphA4 on T regulatory cells and tumor associated macrophages during HNSCC tumor progression;2024-08-13

3. Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck;Frontiers in Oncology;2024-07-01

4. Emerging monoclonal antibody therapy for head and neck squamous cell carcinoma;Expert Opinion on Emerging Drugs;2024-04-02

5. Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives;International Journal of Molecular Sciences;2024-02-28